Associate Professor Helmut Schaider
Course Coordinator
General Practice Clinical Unit
Associate Professor Dermatology
Frazer Institute
+61 7 344 38027
Journal Articles
Benfield, Aurélie H., Vernen, Felicitas, Young, Reuben S.E., Nadal-Bufí, Ferran, Lamb, Henry, Hammerlindl, Heinz, Craik, David J., Schaider, Helmut, Lawrence, Nicole, Blanksby, Stephen J. and Henriques, Sónia Troeira (2024). Cyclic tachyplesin I kills proliferative, non-proliferative and drug-resistant melanoma cells without inducing resistance. Pharmacological Research, 207 107298, 107298. doi: 10.1016/j.phrs.2024.107298
Menon, Dinoop Ravindran, Hammerlindl, Heinz, Gimenez, Gregory, Hammerlindl, Sabrina, Zuegner, Elmar, Torrano, Joachim, Bordag, Natalie, Emran, Abdullah Al, Giam, Maybelline, Denil, Simon, Pavelka, Norman, Tan, Aik-Choon, Sturm, Richard A., Haass, Nikolas K., Rancati, Giulia, Herlyn, Meenhard, Magnes, Christoph, Eccles, Michael R., Fujita, Mayumi and Schaider, Helmut (2023). H3K4me3 remodeling induced acquired resistance through O-GlcNAc transferase. Drug Resistance Updates, 71 100993, 100993. doi: 10.1016/j.drup.2023.100993
Muse, Meghan E., Schaider, Helmut, Oey, Harald, Soyer, H. Peter, Christensen, Brock C. and Stark, Mitchell S. (2023). Distinct HOX gene family DNA methylation profiles in histologically normal skin dependent on dermoscopic pattern of adjacent nevi. Journal of Investigative Dermatology, 143 (9), 1830-1834. doi: 10.1016/j.jid.2023.03.1653
Torrano, Joachim, Hishon, Matt, Robinson, Mitchell, Raphael, Anthony, Wu, Jason, Betz‐Stablein, Brigid, Kopera, Daisy, Soyer, Hans Peter and Schaider, Helmut (2023). Three‐dimensional multispectral facial imaging to monitor actinic damage treated with 5‐fluorouracil. JEADV Clinical Practice, 2 (2), 273-281. doi: 10.1002/jvc2.122
Allen, Nicholas C., Martin, Andrew J., Snaidr, Victoria A., Eggins, Renee, Chong, Alvin H., Fernandéz-Peñas, Pablo, Gin, Douglas, Sidhu, Shireen, Paddon, Vanessa L., Banney, Leith A., Lim, Adrian, Upjohn, Edward, Schaider, Helmut, Ganhewa, Aparna D., Nguyen, Jennifer, Mckenzie, Catriona A., Prakash, Saurabh, Mclean, Catriona, Lochhead, Alistair, Ibbetson, Jan, Dettrick, Andrew, Landgren, Anthony, Allnutt, Katherine J., Allison, Clare, Davenport, Rachael B., Mumford, Blake P., Wong, Brittany, Stagg, Brendan, Tedman, Alexander ... Damian, Diona L. (2023). Nicotinamide for skin-cancer chemoprevention in transplant recipients. New England Journal of Medicine, 388 (9), 804-812. doi: 10.1056/NEJMoa2203086
Khosrotehrani, Kiarash and Schaider, Helmut (2023). Tribute to reviewers. Australasian Journal of Dermatology, 64 (1), 162-166. doi: 10.1111/ajd.13990
Soyer, H. Peter, O’Hara, Montana, V. Silva, Carina, Horsham, Caitlin, Jayasinghe, Dilki, Sanjida, Saira, Schaider, Helmut, Aitken, Joanne, Sturm, Richard A., Prow, Tarl, Menzies, Scott W. and Janda, Monika (2023). Skin cancer excisions and histopathology outcomes when following a contemporary population‐based cohort longitudinally with 3D total‐body photography. Skin Health and Disease, 3 (2) e216, e216. doi: 10.1002/ski2.216
Muse, Meghan E., Bergman, Drew T., Salas, Lucas A., Tom, Lisa N., Tan, Jean-Marie, Laino, Antonia, Lambie, Duncan, Sturm, Richard A., Schaider, Helmut, Soyer, H. Peter, Christensen, Brock C. and Stark, Mitchell S. (2022). Genome-scale DNA methylation analysis identifies repeat element alterations that modulate the genomic stability of melanocytic nevi. The Journal of Investigative Dermatology, 142 (7), 1893-1902.e7. doi: 10.1016/j.jid.2021.11.025
Sanjida, Saira, Betz-Stablein, Brigid, Atkinson, Victoria, Janda, Monika, Barsoum, Ramez, Edwards, Harrison Aljian, Chiu, Frank, Tran, My Co, Soyer, H. Peter and Schaider, Helmut (2022). In-depth characterisation of real-world advanced melanoma patients receiving immunotherapies and/or targeted therapies: a case series. Cancers, 14 (11) 2801, 2801. doi: 10.3390/cancers14112801
Chong, Sharene, Wong, Ho Yi, Althabteh, Ahmad, Cox, Charlotte, Stevenson, Paul H., Brown, Susan, Griffin, Anthony, Isbel, Nicole, Siller, Gregory, Soyer, H. Peter, Schaider, Helmut, Roy, Edwige, Campbell, Scott, Green, Adele C. and Khosrotehrani, Kiarash (2022). Chemoprevention of cutaneous squamous cell carcinoma and its precursors in solid organ transplant recipients using topical sirolimus: a randomized, double-blind, placebo-controlled pilot trial. Journal of the American Academy of Dermatology, 87 (5), 1163-1166. doi: 10.1016/j.jaad.2022.02.039
Horsham, Caitlin, O'Hara, Montana, Sanjida, Saira, Ma, Samantha, Jayasinghe, Dilki, Green, Adele C, Schaider, Helmut, Aitken, Joanne F, Sturm, Richard A, Prow, Tarl, Soyer, H. Peter and Janda, Monika (2022). Experience of 3D total-body photography to monitor naevi: Results from an Australian general population-based cohort study. JMIR Dermatology, 5 (2) e37034, e37034. doi: 10.2196/37034
Wang, Jing, Kao, Yung‐Ching, Zhou, Quan, Wuethrich, Alain, Stark, Mitchell S., Schaider, Helmut, Soyer, H. Peter, Lin, Lynlee L. and Trau, Matt (2021). An integrated microfluidic‐SERS platform enables sensitive phenotyping of serum extracellular vesicles in early stage melanomas. Advanced Functional Materials, 32 (3) 2010296, 1-9. doi: 10.1002/adfm.202010296
Rayner, Jenna E., Duffy, David L., Smit, Darren J., Jagirdar, Kasturee, Lee, Katie J., De’Ambrosis, Brian, Smithers, B. Mark, McMeniman, Erin K., McInerney-Leo, Aideen M., Schaider, Helmut, Stark, Mitchell S., Soyer, H. Peter and Sturm, Richard A. (2020). Germline and somatic albinism variants in amelanotic/hypomelanotic melanoma: increased carriage of TYR and OCA2 variants. PLoS ONE, 15 (9) e0238529, e0238529. doi: 10.1371/journal.pone.0238529
Duffy, David L., Jagirdar, Kasturee, Lee, Katie J., McWhirter, Seamus R., McMeniman, Erin K., De’Ambrosis, Brian, Pflugfelder, Annette, Rayner, Jenna E., Whiteman, David C., Brown, Matthew A., Martin, N.G., Smithers, B.M., Schaider, Helmut, Soyer, H. Peter and Sturm, Richard A. (2020). Genes determining nevus count and dermoscopic appearance in Australian melanoma cases and controls. Journal of Investigative Dermatology, 140 (2), 498-501.e17. doi: 10.1016/j.jid.2019.05.032
Menon, Dinoop Ravindran, Hammerlindl, Heinz, Torrano, Joachim, Schaider, Helmut and Fujita, Mayumi (2020). Epigenetics and metabolism at the crossroads of stress-induced plasticity, stemness and therapeutic resistance in cancer. Theranostics, 10 (14), 6261-6277. doi: 10.7150/thno.42523
Read, Tavis, Lonne, Michael, Sparks, David S., David, Michael, Wagels, Michael, Schaider, Helmut, Soyer, Peter H. and Smithers, Mark B. (2019). Response to Stahlie et al regarding “A systematic review and meta-analysis of locoregional treatments for in-transit melanoma”. Journal of Surgical Oncology, 120 (6), 1058-1059. doi: 10.1002/jso.25686
Al Emran, Abdullah, Marzese, Diego M., Menon, Dinoop R., Hammerlindl, Heinz, Ahmed, Farzana, Richtig, Erika, Duijf, Pascal, Hoon, Dave S. B. and Schaider, Helmut (2019). Commonly integrated epigenetic modifications of differentially expressed genes lead to adaptive resistance in cancer. Epigenomics, 11 (7), 723-737. doi: 10.2217/epi-2018-0173
Heitzer, Ellen, Groenewoud, Arwin, Meditz, Katharina, Lohberger, Birgit, Liegl-Atzwanger, Bernadette, Prokesch, Andreas, Kashofer, Karl, Behrens, Diana, Haybaeck, Johannes, Kolb-Lenz, Dagmar, Koefeler, Harald, Riedl, Sabrina, Schaider, Helmut, Fischer, Carina, Snaar-Jagalska, B. Ewa, de’Jong, Danielle, Szuhai, Karoly, Zweytick, Dagmar and Rinner, Beate (2019). Human melanoma brain metastases cell line MUG-Mel1, isolated clones and their detailed characterization. Scientific Reports, 9 (1) 4096, 4096. doi: 10.1038/s41598-019-40570-1
Torrano, Joachim, Al Emran, Abdullah, Hammerlindl, Heinz and Schaider, Helmut (2019). Emerging roles of H3K9me3, SETDB1 and SETDB2 in therapy-induced cellular reprogramming. Clinical Epigenetics, 11 (1) 43, 43. doi: 10.1186/s13148-019-0644-y
Emran, Abdullah Al, Chinna Chowdary, Brinda Reddy, Ahmed, Farzana, Hammerlindl, Heinz, Huefner, Antje, Haass, Nikolas K., Schuehly, Wolfgang and Schaider, Helmut (2019). Magnolol induces cell death through PI3K/Akt-mediated epigenetic modifications boosting treatment of BRAF- and NRAS-mutant melanoma. Cancer Medicine, 8 (3), 1186-1196. doi: 10.1002/cam4.1978
Emran, Abdullah Al, Chinna Chowdary, Brinda Reddy, Ahmed, Farzana, Hammerlindl, Heinz, Huefner, Antje, Haass, Nikolas K., Schuehly, Wolfgang and Schaider, Helmut (2019). Cover image. Cancer Medicine, 8 (3), i-i. doi: 10.1002/cam4.2129
Read, Tavis, Lonne, Michael, Sparks, David S., David, Michael, Wagels, Michael, Schaider, Helmut, Soyer, H. Peter and Smithers, B. Mark (2019). A systematic review and meta-analysis of locoregional treatments for in-transit melanoma. Journal of Surgical Oncology, 119 (7) jso.25686, 887-896. doi: 10.1002/jso.25400
Deen, Jacqueline and Schaider, Helmut (2019). The use of cinacalcet for the treatment of calciphylaxis in patients with chronic kidney disease: a comprehensive review. Australasian Journal of Dermatology, 60 (3), e186-e194. doi: 10.1111/ajd.12992
Laino, Antonia, Shepherd, Benjamin, Atkinson, Victoria, Fu, Hong, Soyer, H. Peter and Schaider, Helmut (2018). Tumoral melanosis associated with combined BRAF/MEK inhibition (dabrafenib/trametinib) in metastatic melanoma. JAAD Case Reports, 4 (9), 921-923. doi: 10.1016/j.jdcr.2018.06.024
Stark, Mitchell S., Tan, Jean-Marie, Tom, Lisa, Jagirdar, Kasturee, Lambie, Duncan, Schaider, Helmut, Soyer, H. Peter and Sturm, Richard A. (2018). Whole-exome sequencing of acquired nevi identifies mechanisms for development and maintenance of benign neoplasms (vol 138, pg 1636, 2018). Journal of Investigative Dermatology, 138 (9), 2085-2085. doi: 10.1016/j.jid.2018.06.174
Koh, Uyen, Janda, Monika, Aitken, Joanne F., Duffy, David L., Menzies, Scott, Sturm, Richard A., Schaider, Helmut, Betz-Stablein, Brigid, Prow, Tarl, Soyer, H. Peter and Green, Adele C. (2018). ‘Mind your Moles’ study: protocol of a prospective cohort study of melanocytic naevi. BMJ Open, 8 (9) e025857, e025857. doi: 10.1136/bmjopen-2018-025857
Joseph, Shannon R., Gaffney, Daniel, Barry, Rachael, Hu, Lingbo, Banushi, Blerida, Wells, James W., Lambie, Duncan, Strutton, Geoff, Porceddu, Sandro V., Burmeister, Bryan, Leggatt, Graham R., Schaider, Helmut, Dolcetti, Riccardo, Frazer, Ian H., Saunders, Nicholas A., Foote, Matthew, Soyer, H. Peter and Simpson, Fiona (2018). An ex vivo human tumour assay reveals distinct patterns of EGFR trafficking in squamous cell carcinoma correlating to therapeutic outcomes. Journal of Investigative Dermatology, 139 (1), 213-223. doi: 10.1016/j.jid.2018.06.190
Thomas, S, Laino, A, Sturm, R, Nufer, K, Lambie, D, Shepherd, B, Atkinson, V, Adams, L, Soyer, H P and Schaider, H (2018). Focal regression of a primary melanoma, fading lentigines, and poliosis in metastatic melanoma treated with anti-PD-1. Journal of the European Academy of Dermatology and Venereology : JEADV, 32 (5), e176-e177. doi: 10.1111/jdv.14678
Hammerlindl, Heinz, Ravindran Menon, Dinoop, Hammerlindl, Sabrina, Emran, Abdullah Al, Torrano, Joachim, Sproesser, Katrin, Thakkar, Divya, Xiao, Min, Atkinson, Victoria G., Gabrielli, Brian, Haass, Nikolas K., Herlyn, Meenhard, Krepler, Clemens and Schaider, Helmut (2018). Acetylsalicylic acid governs the effect of sorafenib in RAS- mutant cancers. Clinical Cancer Research, 24 (5), 1090-1102. doi: 10.1158/1078-0432.CCR-16-2118
Stark, Mitchell S., Tan, Jean-Marie, Tom, Lisa, Jagirdar, Kasturee, Lambie, Duncan, Schaider, Helmut, Soyer, H. Peter and Sturm, Richard A. (2018). Whole-exome sequencing of acquired nevi identifies mechanisms for development and maintenance of benign neoplasms. Journal of Investigative Dermatology, 138 (7), 1636-1644. doi: 10.1016/j.jid.2018.02.012
Tan, J. M., Tom, L. N., Jagirdar, K., Lambie, D., Schaider, H., Sturm, R. A., Soyer, H. P. and Stark, M. S. (2018). The BRAF and NRAS mutation prevalence in dermoscopic subtypes of acquired naevi reveals constitutive MAPK pathway activation. British Journal of Dermatology, 178 (1), 191-197. doi: 10.1111/bjd.15809
Emran, Abdullah Al, Marzese, Diego M., Menon, Dinoop Ravindran, Stark, Mitchell S., Torrano, Joachim, Hammerlindl, Heinz, Zhang, Gao, Brafford, Patricia, Salomon, Matthew P., Nelson, Nellie, Hammerlindl, Sabrina, Gupta, Deepesh, Mills, Gordon B., Lu, Yiling, Sturm, Richard A., Flaherty, Keith, Hoon, Dave S. B., Gabrielli, Brian, Herlyn, Meenhard and Schaider, Helmut (2017). Distinct histone modifications denote early stress-induced drug tolerance in cancer. Oncotarget, 9 (9), 8206-8222. doi: 10.18632/oncotarget.23654
Aberer, Elisabeth, Surtov-Pudar, Milana, Wilfinger, Daniel, Deutsch, Alexander, Leitinger, Gerd and Schaider, Helmut (2017). Co-culture of human fibroblasts and Borrelia burgdorferi enhances collagen and growth factor mRNA. Archives of Dermatological Research, 310 (2), 117-126. doi: 10.1007/s00403-017-1797-1
Hammerlindl, Heinz and Schaider, Helmut (2017). Tumor cell-intrinsic phenotypic plasticity facilitates adaptive cellular reprogramming driving acquired drug resistance. Journal of Cell Communication and Signaling, 12 (1), 133-141. doi: 10.1007/s12079-017-0435-1
Schaider, H and Sturm, R A (2017). The evolving universe of BRAF mutations in melanoma. The British Journal of Dermatology, 177 (4), 893-893. doi: 10.1111/bjd.15829
McWhirter, Seamus R, Duffy, David L, Lee, Katie J, Wimberley, Glen, McClenahan, Philip, Ling, Natalie, Ardigo, Marco, Schaider, Helmut, Soyer, H Peter and Sturm, Richard A (2017). Classifying dermoscopic patterns of naevi in a case-control study of melanoma. PloS One, 12 (10) e0186647, 1-10. doi: 10.1371/journal.pone.0186647
Read, Tavis, Webber, Scott, Thomas, Janine, Wagels, Michael, Schaider, Helmut, Soyer, H. Peter and Smithers, B. Mark (2017). Protocol for the TIDAL Melanoma Study: topical imiquimod or diphenylcyclopropenone for the management of cutaneous in-transit melanoma metastases-a phase II, single centre, randomised, pilot study. BMJ Open, 7 (10) e016816, 1-8. doi: 10.1136/bmjopen-2017-016816
Schaider, H. and Sturm, R. A. (2017). A path through the reticulate pigmentation disorder jungle. British Journal of Dermatology, 177 (4), 893-893. doi: 10.1111/bjd.15805
Somasundaram, Rajasekharan, Zhang, Gao, Fukunaga-Kalabis, Mizuho, Perego, Michela, Krepler, Clemens, Xu, Xiaowei, Wagner, Christine, Hristova, Denitsa, Zhang, Jie, Tian, Tian, Wei, Zhi, Liu, Qin, Garg, Kanika, Griss, Johannes, Hards, Rufus, Maurer, Margarita, Hafner, Christine, Mayerhofer, Marius, Karanikas, Georgios, Jalili, Ahmad, Bauer-Pohl, Verena, Weihsengruber, Felix, Rappersberger, Klemens, Koller, Josef, Lang, Roland, Hudgens, Courtney, Chen, Guo, Tetzlaff, Michael, Wu, Lawrence ... Wagner, Stephan N. (2017). Tumor-associated B-cells induce tumor heterogeneity and therapy resistance. Nature Communications, 8 (1) 607, 607. doi: 10.1038/s41467-017-00452-4
Read, T., Webber, S., Tan, J., Wagels, M., Schaider, H., Soyer, H. P. and Smithers, B. M. (2017). Diphenylcyclopropenone for the treatment of cutaneous in-transit melanoma metastases - results of a prospective, non-randomized, single-centre study. Journal of the European Academy of Dermatology and Venereology, 31 (12), 2030-2037. doi: 10.1111/jdv.14422
Richtig, G., Byrom, L., Kupsa, R., Schaider, H., Hofmann-Wellenhof, R., Wolf, I. H., Soyer, H. P. and Richtig, E. (2017). Pregnancy as driver for melanoma. British Journal of Dermatology, 177 (3), 854-857. doi: 10.1111/bjd.15124
Keller, Hilary R., Zhang, Xin, Li, Li, Schaider, Helmut and Wells, James W. (2017). Overcoming resistance to targeted therapy with immunotherapy and combination therapy for metastatic melanoma. Oncotarget, 8 (43), 75675-75686. doi: 10.18632/oncotarget.18523
Riedl, Sabrina, Rinner, Beate, Schaider, Helmut, Liegl-Atzwanger, Bernadette, Meditz, Katharina, Preishuber-Pfluegl, Julia, Grissenberger, Sarah, Lohner, Karl and Zweytick, Dagmar (2017). In vitro and in vivo cytotoxic activity of human lactoferricin derived antitumor peptide R-DIM-P-LF11-334 on human malignant melanoma. Oncotarget, 8 (42), 71817-71832. doi: 10.18632/oncotarget.17823
Richtig, Georg, Aigelsreiter, Ariane, Kashofer, Karl, Talakic, Emina, Kupsa, Romana, Schaider, Helmut and Richtig, Erika (2016). Two case reports of rare BRAF mutations in exon 11 and exon 15 with discussion of potential treatment options. Case Reports in Oncology, 9 (3), 543-546. doi: 10.1159/000449125
Fox, Carly, Lambie, Duncan, Wilmott, James S., Pinder, Alex, Pavey, Sandra, Lê Cao, Kim-Anh, Akalin, Taner, Karaarslan, Isil Kilinc, Ozdemir, Fezal, Scolyer, Richard A., Yamada, Miko, Soyer, H. Peter, Schaider, Helmut and Gabrielli, Brian (2016). Multiparameter analysis of naevi and primary melanomas identifies a subset of naevi with elevated markers of transformation. Pigment Cell and Melanoma Research, 29 (4), 444-452. doi: 10.1111/pcmr.12489
Rad, Ehsan Bonyadi, Hammerlindl, Heinz, Wels, Christian, Popper, Ulrich, Menon, Dinoop Ravindran, Breiteneder, Heimo, Kitzwoegerer, Melitta, Hafner, Christine, Herlyn, Meenhard, Bergler, Helmut and Schaider, Helmut (2016). Notch4 signaling induces a mesenchymal- Epithelial-like transition in melanoma cells to suppress malignant behaviors. Cancer Research, 76 (7), 1690-1697. doi: 10.1158/0008-5472.CAN-15-1722
Lee, S., Duffy, D.L., Mcclenahan, P., Lee, K. J., McEniery, E., Burke, B., Jagirdar, K., Martin, N.G., Sturm, R.A., Soyer, H.P. and Schaider, H. (2016). Heritability of naevus patterns in an adult twin cohort from the Brisbane Twin Registry: A cross-sectional study. British Journal of Dermatology, 174 (2), 356-363. doi: 10.1111/bjd.14291
Fox, Carly, Schaider, Helmut, Akalin, Taner, Turkmen, Meltem, Sturm, Rick, Lambie, Duncan, Karaarslan, Isil K., Soyer, H. Peter, Ozdemir, Fezal and Gabrielli, Brian (2016). A distinct expression profile separates Turkish and Australian melanocytic naevi. Histopathology, 69 (1), 151-154. doi: 10.1111/his.12906
Menon, Dinoop Ravindran and Schaider, Helmut (2015). Microenvironment-driven resistance to BRAF inhibition comes of age. Journal of Investigative Dermatology, 135 (12), 2923-2925. doi: 10.1038/jid.2015.373
Riedl, Sabrina, Leber, Regina, Rinner, Beate, Schaider, Helmut, Lohner, Karl and Zweytick, Dagmar (2015). Human lactoferricin derived di-peptides deploying loop structures induce apoptosis specifically in cancer cells through targeting membranous phosphatidylserine. Biochimica et Biophysica Acta. Biomembranes, 1848 (11), 2918-2931. doi: 10.1016/j.bbamem.2015.07.018
Read, T., Noonan, C., David, M., Wagels, M., Foote, M., Schaider, H., Soyer, H. P. and Smithers, B. M. (2015). A systematic review of non-surgical treatments for lentigo maligna. Journal of the European Academy of Dermatology and Venereology, 30 (5), 1-6. doi: 10.1111/jdv.13252
Ravindran Menon, D., Das, S., Krepler, C., Vultur, A., Rinner, B., Schauer, S., Kashofer, K., Wagner, K., Zhang, G., Bonyadi Rad, E., Haass, N. K., Soyer, H. P., Gabrielli, B., Somasundaram, R., Hoefler, G., Herlyn, M. and Schaider, H. (2015). A stress-induced early innate response causes multidrug tolerance in melanoma. Oncogene, 34 (34), 4448-4459. doi: 10.1038/onc.2014.372
Menon, D. Ravindran, Das, S., Krepler, C., Vultur, A., Rinner, B., Schauer, S., Kashofer, K., Wagner, K., Zhang, G., Rad, E. Bonyadi, Haass, N. K., Soyer, H. P., Gabrielli, B., Somasundaram, R., Hoefler, G., Herlyn, M. and Schaider, H. (2015). Corrigendum: a stress-induced early innate response causes multidrug tolerance in melanoma (vol 34, pg 4448, 2015). Oncogene, 34 (34), 4545-4545. doi: 10.1038/onc.2014.432
Ramprecht, Claudia, Jaritz, Hannah, Streith, Ingo, Zenzmaier, Elfriede, Kofeler, Harald, Hofmann-Wellenhof, Rainer, Schaider, Helmut and Hermetter, Albin (2015). Toxicity of oxidized phosphatidylcholines in cultured human melanoma cells. Chemistry and Physics of Lipids, 189, 39-47. doi: 10.1016/j.chemphyslip.2015.05.007
Tan, Jean-Marie, Lin, Lynlee L., Lambie, Duncan, Flewell-Smith, Ross, Jagirdar, Kasturee, Schaider, Helmut, Sturm, Richard A., Prow, Tari W. and Soyer, H. Peter (2015). BRAF wild-type melanoma in situ arising in a BRAF V600E mutant dysplastic nevus. JAMA Dermatology, 151 (4), 417-421. doi: 10.1001/jamadermatol.2014.3775
Joshi, Shripad, Wels, Christian, Beham-Schmid, Christine, Fukunaga-Kalabis, Mizuho, Holmen, Sheri L, Otte, Marcus, Herlyn, Meenhard, Waldhoer, Maria and Schaiderm Helmut (2015). Gα13 mediates human cytomegalovirus-encoded chemokine receptor US28-induced cell death in melanoma. International Journal of Cancer, 137 (6), 1503-1508. doi: 10.1002/ijc.29506
Lim, Yah Leng, Taimre, Thomas, Bertling, Karl, Dean, Paul, Indjin, Dragan, Valavanis, Alexander, Khanna, Suraj P., Lachab, Mohammad, Schaider, Helmut, Prow, Tarl W., Soyer, H. Peter, Wilson, Stephen J., Linfield, Edmund H., Davies, A. Giles and Rakic, Aleksandar D. (2014). High-contrast coherent terahertz imaging of porcine tissue via swept-frequency feedback interferometry. Biomedical Optics Express, 5 (11), 3981-3989. doi: 10.1364/BOE.5.003981
Rakic, Aleksandar, Karl Bertling, Yah Leng Lim, Wilson, Stephen J., Milan Nikolic, Thomas Taimre, Dragan Indjin, Alexander Valavanis, Edmund H. Linfield, A. Giles Davies, Graeme Walker, Blake Ferguson, Tarl Prow, Helmut Schaider and Soyer, H. Peter (2014). Biomedical applications of terahertz self-mixing interferometry. SPIE Newsroom doi: 10.1117/2.1201409.005613
Riedl, Sabrina, Rinner, Beate, Schaider, Helmut, Lohner, Karl and Zweytick, Dagmar (2014). Killing of melanoma cells and their metastases by human lactoferricin derivatives requires interaction with the cancer marker phosphatidylserine. BioMetals, 27 (5), 981-997. doi: 10.1007/s10534-014-9749-0
Vinod, Manjula, Chennamsetty, Indumathi, Colin, Sophie, Belloy, Loic, De Paoli, Federica, Schaider, Helmut, Graier, Wolfgang F., Frank, Saša, Kratky, Dagmar, Staels, Bart, Chinetti-Gbaguidi, Giulia and Kostner, Gerhard M. (2014). miR-206 controls LXRα expression and promotes LXR-mediated cholesterol efflux in macrophages. Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids, 1841 (6), 827-835. doi: 10.1016/j.bbalip.2014.02.006
Deutsch, Alexander J., Rinner, Beate, Wenzl, Kerstin, Pichler, Martin, Troppan, Katharina, Steinbauer, Elisabeth, Schwarzenbacher, Daniela, Reitter, Sonja, Feichtinger, Julia, Tierling, Sascha, Prokesch, Andreas, Scheideler, Marcel, Krogsdam, Anne, Thallinger, Gerhard G., Schaider, Helmut, Beham-Schmid, Christine and Neumeister, Peter (2014). NR4A1-mediated apoptosis suppresses lymphomagenesis and is associated with a favorable cancer-specific survival in patients with aggressive B-cell lymphomas.. Blood, 123 (15), 2367-2377. doi: 10.1182/blood-2013-08-518878
McClenahan, Phil, Lin, Lynlee L., Tan, Jean-Marie, Flewell-Smith, Ross, Schaider, Helmut, Jagirdar, Kasturee, Atkinson, Victoria, Lambie, Duncan, Prow, Tarl W., Sturm, Richard A. and Soyer, Peter (2014). BRAFV600E Mutation Status of Involuting and Stable Nevi in Dabrafenib Therapy with or without Trametinib. JAMA Dermatology, 150 (10), 1079-1082. doi: 10.1001/jamadermatol.2014.436
Blake T., McClenahan P., Duffy D., Schaider H., McEniery E. and Soyer H.P. (2014). Distribution analyses of acquired melanocytic naevi on the trunk. Dermatology, 228 (3), 269-275. doi: 10.1159/000358217
Menon, Dinoop R., Wels, Christian, Rad, Ehsan Bonyadi, Joshi, Shripad, Knausz, Heike, Lade-Keller, Johanne, Brandner, Johanna M. and Schaider, Helmut (2013). TGF-beta 1 and TNF-alpha differentially regulate Twist1 mediated resistance towards BRAF/MEK inhibition in melanoma. Pigment Cell and Melanoma Research, 26 (6), 912-916. doi: 10.1111/pcmr.12139
Deutsch, Alexander JA, Steinbauer, Elisabeth, Hofmann, Nicole A, Strunk, Dirk, Gerlza, Tanja, Beham-Schmid, Christine, Schaider, Helmut and Neumeister, Peter (2013). Chemokine receptors in gastric MALT lymphoma: Loss of CXCR4 and upregulation of CXCR7 is associated with progression to diffuse large B-cell lymphoma. Modern Pathology, 26 (2), 182-194. doi: 10.1038/modpathol.2012.134
Kretschmer, Nadine, Rinner, Beate, Deutsch, Alexander J. A., Lohberger, Birgit, Knausz, Heike, Kunert, Olaf, Blunder, Martina, Boechzelt, Herbert, Schaider, Helmut and Bauer, Rudolf (2012). Naphthoquinones from Onosma paniculata induce cell-cycle arrest and apoptosis in melanoma cells. Journal of Natural Products, 75 (5), 865-869. doi: 10.1021/np2006499
Wels, Christian, Joshi, Shripad, Koefinger, Petra, Bergler, Helmut and Schaider, Helmut (2011). Transcriptional activation of ZEB1 by slug leads to cooperative regulation of the epithelial-mesenchymal transition-like phenotype in melanoma. Journal of Investigative Dermatology, 131 (9), 1877-1885. doi: 10.1038/jid.2011.142
Koefinger, Petra, Wels, Christian, Joshi, Shripad, Damm, Sabine, Steinbauer, Elisabeth, Beham-Schmid, Christine, Frank, Sasa, Bergler, Helmut and Schaider, Helmut (2011). The cadherin switch in melanoma instigated by HGF is mediated through epithelial-mesenchymal transition regulators. Pigment Cell and Melanoma Research, 24 (2), 382-385. doi: 10.1111/j.1755-148X.2010.00807.x
Riedl, Sabrina, Rinner, Beate, Asslaber, Martin, Schaider, Helmut, Walzer, Sonja, Novak, Alexandra, Lohner, Karl and Zweytick, Dagmar (2011). In search of a novel target - Phosphatidylserine exposed by non-apoptotic tumor cells and metastases of malignancies with poor treatment efficacy. Biochimica et Biophysica Acta - Biomembranes, 1808 (11), 2638-2645. doi: 10.1016/j.bbamem.2011.07.026
Damm, Sabine, Koefinger, Petra, Stefan, Martina, Wels, Christian, Mehes, Gabor, Richtig, Erika, Kerl, Helmut, Otte, Marcus and Schaider, Helmut (2010). HGF-promoted motility in primary human melanocytes depends on CD44v6 regulated via NF-kappa B, Egr-1, and C/EBP-beta. Journal of Investigative Dermatology, 130 (7), 1893-1903. doi: 10.1038/jid.2010.45
Tschische, Pia, Moser, Elisabeth, Thompson, Dawn, Vischer, Henry F., Parzmair, Gerald P., Pommer, Veronika, Platzer, Wolfgang, Schwarzbraun, Thomas, Schaider, Helmut, Smit, Martine J., Martini, Lene, Whistler, Jennifer L. and Waldhoer, Maria (2010). The G-protein coupled receptor associated sorting protein GASP-1 regulates the signalling and trafficking of the viral chemokine receptor US28. Traffic, 11 (5), 660-674. doi: 10.1111/j.1600-0854.2010.01045.x
Rinner, Beate, Kretschmer, Nadine, Knausz, Heike, Mayer, Andrea, Boechzelt, Herbert, Hao, Xiao-Jiang, Heubl, Guenther, Efferth, Thomas, Schaider, Helmut and Bauer, Rudolf (2010). A petrol ether extract of the roots of Onosma paniculatum induces cell death in a caspase dependent manner. Journal of Ethnopharmacology, 129 (2), 182-188. doi: 10.1016/j.jep.2010.02.006
Gutwein, Paul, Schramme, Anja, Sinke, Nina, Abdel-Bakky, Mohamed Sadek, Voss, Beren, Obermuller, Nicholas, Doberstein, Kai, Koziolek, Michael, Fritzsche, Florian, Johannsen, Manfred, Jung, Klaus, Schaider, Helmut, Altevogt, Peter, Ludwig, Andreas, Pfeilschifter, Josef and Kristiansen, Glen (2009). Tumoural CXCL16 expression is a novel prognostic marker of longer survival times in renal cell cancer patients. European Journal of Cancer, 45 (3), 478-489. doi: 10.1016/j.ejca.2008.10.023
Frühauf, Julia, Schaider, Helmut, Massone, Cesare, Kerl, Helmut and Müllegger, Robert R. (2008). Carbamazepine as the only effective treatment in a 52-year-old man with trigeminal trophic syndrome. Mayo Clinic Proceedings, 83 (4), 502-504. doi: 10.4065/83.4.502
Deutsch, A. J. A., Aigelsreiter, A., Steinbauer, E., Fruhwirth, M., Kerl, H., Beham-Schmid, C., Schaider, H. and Neumeister, P. (2008). Distinct signatures of B-cell homeostatic and activation-dependent chemokine receptors in the development and progression of extragastric MALT lymphomas. Journal of Pathology, 215 (4), 431-444. doi: 10.1002/path.2372
Seidl, Hannes, Weger, Wolfgang, Wolf, Peter, Kerl, Helmut and Schaider, Helmut (2008). Lack of oncogenic mutations in the c-Met catalytic tyrosine kinase domain in acral lentiginous melanoma. International Journal of Dermatology, 47 (12), 1327-1329. doi: 10.1111/j.1365-4632.2008.03818.x
Seidl, Hannes, Richtig, Erika, Tilz, Hemma, Stefan, Martina, Schmidbauer, Ulrike, Asslaber, Martin, Zatloukal, Kurt, Herlyn, Meenhard and Schaider, Helmut (2007). Profiles of chemokine receptors in melanocytic lesions: de novo expression of CXCR6 in melanoma. Human Pathology, 38 (5), 768-780. doi: 10.1016/j.humpath.2006.11.013
Gruss C.J., Satyamoorthy K., Berking C., Lininger J., Nesbit M., Schaider H., Liu Z.-J., Oka M., Hsu M.-Y., Shirakawa T., Li G., Bogenrieder T., Carmeliet P., El-Deiry W.S., Eck S.L., Rao J.S., Baker A.H., Bennet J.T., Crombleholme T.M., Velazquez O., Karmacharya J., Margolis D.J., Wilson J.M., Detmar M., Skobe M., Robbins P.D., Buck C. and Herlyn M. (2003). Stroma formation and angiogenesis by overexpression of growth factors, cytokines, and proteolytic enzymes in human skin grafted to SCID mice. Journal of Investigative Dermatology, 120 (4), 683-692. doi: 10.1046/j.1523-1747.2003.12112.x
Schaider, Helmut, Oka, Masahiro, Bogenrieder, Thomas, Nesbit, Mark, Satyamoorthy, Kapaettu, Berking, Carola, Matsushima, Kouji and Herlyn, Meenhard (2003). Differential response of primary and metastatic melanomas to neutrophils attracted by IL-8. International Journal of Cancer, 103 (3), 335-343. doi: 10.1002/ijc.10775
Li, Gang, Schaider, Helmut, Satyamoorthy, Kapaettu, Hanakawa, Yasushi, Hashimoto, Koji and Herlyn, Meenhard (2001). Downregulation of E-cadherin and Desmoglein 1 by autocrine hepatocyte growth factor during melanoma development. Oncogene, 20 (56), 8125-8135. doi: 10.1038/sj.onc.1205034
Berking, C, Takemoto, R, Schaider, H, Showe, L, Satyamoorthy, K, Robbins, P and Herlyn, M (2001). Transforming growth factor-beta 1 increases survival of human melanoma through stroma remodeling. Cancer Research, 61 (22), 8306-8316.
Nesbit, M, Schaider, H, Berking, C, Shih, DT, Hsu, MY, McBrian, M, Crombleholme, TM, Elenitsas, R, Buck, C and Herlyn, M (2001). alpha 5 and alpha 2 integrin gene transfers mimic the PDGF-B-induced transformed phenotype of fibroblasts in human skin. Laboratory Investigation, 81 (9), 1263-1274. doi: 10.1038/labinvest.3780340
Nesbit, M, Schaider, H, Miller, TH and Herlyn, M (2001). Low-level monocyte chemoattractant protein-1 stimulation of monocytes leads to tumor formation in nontumorigenic melanoma cells. Journal of Immunology, 166 (11), 6483-6490. doi: 10.4049/jimmunol.166.11.6483
Oka, M, Berking, C, Nesbit, M, Satyamoorthy, K, Schaider, H, Murphy, G, Ichihashi, M, Sauter, E and Herlyn, M (2000). Interleukin-8 overexpression is present in pyoderma gangrenosum ulcers and leads to ulcer formation in human skin xenografts. Laboratory Investigation, 80 (4), 595-604. doi: 10.1038/labinvest.3780064
Schaider, H, Soyer, HP, Heider, KH, Hofmann-Wellenhof, R, Zatloukal, K, Smolle, J and Kerl, H (1998). CD44 and variants in melanocytic skin neoplasms. Journal of Cutaneous Pathology, 25 (4), 199-203. doi: 10.1111/j.1600-0560.1998.tb01719.x
Schaider, H, Seidl, H, Berger, MR, Hofmann-Wellenhof, R, Tritthart, HA and Smolle, J (1998). Hexadecylphosphocholine inhibits invasion of mouse T-cell lymphoma cells in two different invasion assays. Anticancer Research, 18 (2A), 995-998.
Schaider, H, RechWeichselbraun, I, Richtig, E, Seidl, H, Soyer, HP, Smolle, J and Kerl, H (1997). Circulating adhesion molecules as prognostic factors for cutaneous melanoma. Journal of the American Academy of Dermatology, 36 (2), 209-213. doi: 10.1016/S0190-9622(97)70282-2
Neumeister P., Hoefler G., Beham-Schmid C., Schmidt H., Apfelbeck U., Schaider H., Linkesch W. and Sill H. (1997). Deletion analysis of the p16 tumor suppressor gene in gastrointestinal mucosa-associated lymphoid tissue lymphomas. Gastroenterology, 112 (6), 1871-1875. doi: 10.1053/gast.1997.v112.pm9178679
Schaider, H., Seidl, H., Hofmann-Wellenhof, R., Berger, M. R., Smolle, J. and Kerl, H. (1996). Hexadecylphosphocholine inhibits invasion of mouse T cell lymphoma cells in two different invasion assays. Skin Pharmacology, 9 (2).
Schaider H., Haberkorn U., Berger M.R., Oberdorfer F., Morr I. and Van Kaick G. (1996). Application of α-aminoisobutyric acid, L-methionine, thymidine and 2-fluoro-2-deoxy-D-glucose to monitor effects of chemotherapy in a human colon carcinoma cell line. European Journal of Nuclear Medicine, 23 (1), 55-60. doi: 10.1007/BF01736990
Schaider, H, Haberkorn, U, Stohr, M and Berger, MR (1995). Dinaline inhibits amino acid transport and proliferation of colon carcinoma cells in vitro. Anticancer Research, 15 (6B), 2501-2509.
Petru, E, Haas, J, Schaider, H and Sevin, BU (1995). Is there a correlation between cell cycle perturbations and chemosensitivity in ovarian cancer cells exposed to cytotoxic drugs in vitro?. Gynakologisch-Geburtshilfliche Rundschau, 35, 15-18.
Schaider H., Haberkorn U., Petru E. and Berger M.R. (1995). Combination treatment based on metabolic effects of dinaline. Journal of Cancer Research and Clinical Oncology, 121 (4), 203-210. doi: 10.1007/BF01366963
Petru, E., Haas, J., Schaider, H. and Sevin, B. U. (1995). Korrelieren zellzyklus-verände-rungen von humanen ovarial-karzinomzellen nach exposition gegenüber zytostatika in vitro mit der zytotoxizität?. Gynakologisch-geburtshilfliche Rundschau, 35 (1), 15-18. doi: 10.1159/000272557
Petru, E, Pickel, H, Heydarfadai, M, Lahousen, M, Haas, J, Schaider, H and Tamussino, K (1992). Nongenital Cancers Metastatic to the Ovary. Gynecologic Oncology, 44 (1), 83-86. doi: 10.1016/0090-8258(92)90017-D
Petru, E, Pickel, H, Heydarfadai, M, Tamussino, K, Lahousen, M and Schaider, H (1991). Experience with Stromal Tumors and Germ-Cell Tumors of the Ovary. International Journal of Gynecological Cancer, 1 (1), 9-14. doi: 10.1111/j.1525-1438.1991.tb00032.x
Conference Papers
Kangachar, S. Asgharzadeh, Ahmed, F., Al Emran, A., Boyle, G., Spoerri, L., Schaider, H. and Haass, N.K. (2024). Environmentally stressed drug-naïve melanoma cell subpopulations share a molecular signature with drug-induced early persister cells. Society for Investigative Dermatology (SID) 2024 Meeting, Dallas, TX United States, 15-18 May 2024. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.jid.2024.06.641
Kangachar, S. Asgharzadeh, Ahmed, F., Al Emran, A., Boyle, G., Spoerri, L., Schaider, H. and Haass, N. K. (2024). Environmentally stressed drug-naive melanoma cell subpopulations share a molecular signature with drug-induced early persister cells. Society for Investigative Dermatology (SID) 2024 Meeting, Dallas, TX, United States, 15-18 May 2024. Oxford, United Kingdom: Elsevier.
Guan, Yimeng, Robitaille, Melanie, Torrano, Joachim, Haass, Nikolas, Roberts-Thomson, Sarah, Monteith, Gregory and Schaider, Helmut (2024). A calcium influx pathway regulates adaptive melanoma drug tolerance. ASDR 2024 Annual Scientific Meeting, Sydney, NSW Australia, 18-20 July 2024.
Robitaille, Melanie, Schaider, Helmut, Monteith, Gregory and Roberts-Thomson, Sarah (2024). Exploring calcium signalling remodelling during adaptive cancer drug tolerance. Calcium Signaling- Gordon Research Conference, Barga, Lucca, Italy, 30 June - 5 July 2024.
Menon, Dinoop Ravindran, Hammerlindl, Heinz, Gimenez, Gregory, Zuegner, Elmar, Magens, Christoph, Eccles, Michael, Fujita, Mayumi and Schaider, Helmut (2024). O-GlcNAc transferase drives the proliferative state in adaptive drug tolerance. AACR Annual Meeting 2024, San Diego, CA United States, 5-10 April 2024. Philadelphia, PA United States: American Association for Cancer Research. doi: 10.1158/1538-7445.am2024-lb293
Robitaille, Mélanie, Schaider, Helmut, Roberts-Thomson, Sarah and Monteith, Gregory (2023). Exploring calcium signalling remodelling during adaptive cancer drug tolerance. ASCEPT Annual Scientific Meeting, Sydney, NSW Australia, 20-23 November 2023.
Ladwa, R., Monkman, J., Sadeghirad, H., Cooper, C., Belz, G., Bowman, J., Schaider, H., Liu, H., Kulasinghe, A. and Porceddu, S. (2023). High-plex spatial profiling of cutaneous squamous cell carcinoma to identify biomarkers associated with clinical outcomes: The cMIC study. ESMO Congress 2023, Madrid, Spain, 20-24 October 2023. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.annonc.2023.09.2278
Torrano, J., Ravindran-Menon, D., Hammerlindl, H., Hammerlindl, S., Emran, A.A., Bordag, N., Zuegner, E., Haass, N.K., Sadowski, M., Stow, J., Magnes, C., Fujita, M. and Schaider, H. (2023). 1244 Epigenetic and metabolic vulnerabilities of adaptive drug resistance to targeted therapies in melanoma. 1st International Societies for Investigative Dermatology Meeting (ISID 2023), Tokyo, Japan, 10-13 May 2023. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.jid.2023.03.1258
Cox, Charlotte, Lee, Ruby, Liyanage, Upekha, Brown, Susan, Isbel, Nicole, Chambers, Daniel, Griffin, Anthony, Campbell, Scott, Hopkins, Peter, Schaider, Helmut, Soyer, Peter and Khosrotehrani, Kiarash (2023). Anatomical distribution of severe keratinocyte carcinomas in solid organ transplant recipients. HOBOKEN: WILEY.
Muse, Meghan E., Schaider, Helmut, Oey, Harald, Soyer, H. Peter, Christensen, Brock C. and Stark, Mitchell S. (2023). Distinct HOX gene family DNA methylation profiles in histologically normal skin dependent on dermoscopic pattern of adjacent nevi. 114th Annual Meeting of the American Association for Cancer Research (AACR), Orlando Fl, Apr 14-19, 2023. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. doi: 10.1158/1538-7445.AM2023-6000
Spoerri, L., Tonnessen-Murray, C. A., Beaumont, K. A., Hill, D. S., Jurek, R. J., Gunasingh, G., Vanwalleghem, G., Daignault, S., Fane, M. E., Schaider, H., Smith, A., Stehbens, S. J., Weninger, W., Scott, E. E., Gabrielli, B. and Haass, N. (2023). MITF-mediated changes of tumour architecture, tensile stress and in extracellular matrix (ECM) control intratumour heterogeneity in melanoma. Meeting of the Arbeitsgemeinschaft Dermatologische Forschung (ADF), Berlin, Germany, 11-14 March 2020. Chichester, West Sussex United Kingdom: Wiley-Blackwell.
Su, C., Bond, C., Fennell, L., Kerr, G., Jarde, T., Micati, D., Engel, R., Chan, W. H., Hlavca, S., Archer, S., Mcmurrick, P., Hammerlindl, H., Lim, F., Salik, B., Mckeone, D., Hartel, G., Leggett, B., Schaider, H., Abud, H., Boyle, G., Burge, M. and Whitehall, V. (2021). Preclinical study of aspirin and regorafenib combination therapy for colorectal cancer. GESA AGW 2021, Online, 4 - 12 September 2021. HOBOKEN: WILEY.
Economides, A., Mar, V., Soyer, H. P., Schaider, H., Sadeghi, M. and Guitera, P. (2019). ANZMTG NRP 09.18 alert - Assessing teledermatology referral for managing patients in the primary care setting. 2019 Dermcoll, Melbourne, Australia, 18 – 21 May 2019. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia.
Spoerri, L., Tonnessen, C. A., Beaumont, K. A., Hill, D. S., Jurek, R. J., Smith, A., Scott, E., Schaider, H., Gabrielli, B., Weninger, W. and Haass, N. (2019). Microphthalmia-associated transcription factor regulates dynamic heterogeneity and structural integrity in melanoma. 46th Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung (ADF), Munich, Germany, 13-16 March, 2019. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/exd.13859
Faleiro, Rebecca J., Karunarathne, Deshapriya S., Liu, Ji, Boyle, Glen, Hartel, Gunter, Hayward, Nick, Schaider, Helmut, Waddell, Nic, Schmidt, Chris and Wykes, Michelle (2019). Programmed death-1 ligand 2 (PD-L2) on dendritic cells protects T cells from cellular exhaustion during melanoma. Annual Meeting of the American Association for Cancer Research (AACR), Atlanta, GA, United States, 29 March - 3 April, 2019. Philadelphia, PA, United States: American Association for Cancer Research. doi: 10.1158/1538-7445.SABCS18-4112
Emran, A., Marzese, D. M., Menon, D. R., Stark, M., Torrano, J., Hammerlindl, H., Zhang, G., Brafford, P., Hammerlindl, S., Gupta, D., Mills, G. B., Lu, Y., Flaherty, K., Sturm, R., Hoon, D. S. B., Gabrielli, B., Herlyn, M. and Schaider, H. (2018). Distinct epigenetic remodelling defines early stress-induced drug tolerance in melanoma. Australasian College of Dermatologists, 51st Annual Scientific Meeting, Gold Coast, QLD, Australia , 19–22 May 2018. Richmond, VIC, Australia: Wiley-Blackwell Publishing. doi: 10.1111/ajd.16_12815
Riedl, Sabrina, Rinner, Beate, Schaider, Helmut, Liegl-Atzwanger, Bernadette, Wodlej, Christina, Grissenberger, Sarah, Preishuber-Pfluegl, Julia, Lohner, Karl and Zweytick, Dagmar (2018). Fighting melanoma - human lactoferricin derived peptides kill cancer cells by inducing severe stress and apoptosis. 35th European Peptide Symposium, Dublin, Ireland, 26th-31st August, 2018 . Oxford, United Kingdom: John Wiley & Sons .
Emran, A., Chowdhury, B. R., Hammerlindl, H., Ahmed, F., Haass, N. K., Schuehly, W. and Schaider, H. (2018). Magnolol induces cell death through PI3K/Akt mediated epigenetic modifications boosting targeted inhibition in BRAF and NRAS mutant melanoma. Australasian College of Dermatologists, 51st Annual Scientific Meeting, Gold Coast, QLD, Australia, 19-22 May 2018. Hoboken, NJ, United States: Wiley.
Uranowska, K., Kalic, T., Karapandza, K., Ellinger, I., Breiteneder, H., Schaider, H. and Hafner, C. (2018). The expression of chondroitin sulfate proteoglycan 4 (CSPG4) is decreased in BRAF-mutant induced drug-tolerant melanoma cells. 45th Annual Meeting of the Arbeitsgemeinscha-Dermatologische-Forschung (ADF), Zurich Switzerland, Mar 07-10, 2018. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing.
Schukoff, T., Winkler, S., Unterluggauer, J. J., Fechter, K., Greinix, H., Beham-Schmid, C., Schaider, H., Deutsch, A., Prochazka, K. and Neumeister, P. (2018). Distinct expression profiles of chemokine- and nuclear orphan receptors in the development and early progression of follicular lymphoma. Unknown, Unknown, Unknown. Basel, Switzerland: S. Karger AG.
Menon, D. Ravindran, Hammerlindl, H., Emran, A., Torrano, J., Hammerlindl, S., Zhang, G., Krause, L., Somasundaram, R., Sturm, R., Haass, N. K., Flaherty, K., Herlyn, M. and Schaider, H. (2018). Escape form adaptive drug tolerance through OGT and TET1 mediated H3K4me3 remodeling in MAPKi-resistant melanoma. International Investigative Dermatology (IID) Meeting, Orlando, Fl, United States, 16-19 May 2018. London, United Kingdom: Nature Publishing Group. doi: 10.1016/j.jid.2018.03.1252
Stark, Mitchell S., Tan, Jean-Marie, Tom, Lisa, Jagirdar, Kasturee, Lambie, Duncan, Schaider, Helmut, Soyer, H. Peter and Sturm, Richard A. (2018). Whole-exome sequencing of acquired nevi identifies novel mechanisms for development and maintenance of benign neoplasms. Annual Meeting of the American Association for Cancer Research (AACR), Chicago, Illinois, 14-18 April 2018. Philadelphia, PA, United States: American Association for Cancer Research. doi: 10.1158/1538-7445.AM2018-5376
Menon, Dinoop Ravindran, Hammerlindl, Heinz, Al Emran, Abdullah, Torrano, Joachim, Hammerlindl, Sabrina, Zhang, Gao, Somasundaram, Rajasekharan, Sturm, Richard A., Haass, Nikolas K., Flaherty, Keith, Herlyn, Meenhard and Schaider, Helmut (2018). Escape form adaptive drug tolerance through OGT and TET1 mediated H3K4me3 remodeling in MAPKi resistant melanoma. Annual Meeting of the American Association for Cancer Research (AACR), Chicago, IL United States, 14-18 April 2018. Philadelphia, PA United States: American Association of Cancer Research. doi: 10.1158/1538-7445.AM2018-5833
Thomas, S., Schaider, H., Laino, A., Adams, L. and Soyer, P. (2017). Involution of selective melanocytic lesions in a 79 year-old male with metastatic melanoma on immunotherapy. Australasian College of Dermatologists 50th Annual Scientific Meeting, Darling Harbour, New South Wales, Australia, 6–9 May 2017. Richmond, VIC., Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/ajd.21_12652
Riedl, S., Rinner, B., Schaider, H., Liegl-Atzwanger, B., Wodlej, C., Lohner, K. and Zweytick, D. (2017). Human lactoferricin derived peptides trigger apoptosis in malignant melanoma in vitro and in vivo. 19th IUPAB Congress / 11th EBSA Congress, Edinburgh Scotland, 16-20 July 2017. New York, NY, United States: Springer.
Nierfeld, M., Nascimento, P. R., Baesler, K., Knuever, J., Spoerri, L., Schaider, H., Weninger, W. and Haass, N. K. (2016). Rose Bengal melanoma therapy - phototoxicity versus intrinsic cytotoxicity. Asia-Pacific Combined Dermatology Research Conference 2016, Noosa, QLD Australia, 25–28 August 2016. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia.
Menon, D. R., Hammerlindl, H., Emran, A., Thakkar, D., Soyer, H. P., Herlyn, M., Krepler, C. and Schaider, H. (2016). Combination of sorafenib with aspirin synergistically target mutant NRAS melanoma. Asia‐Pacific Combined Dermatology Research Conference 2016, Noosa, QLD Australia, 25–28 August 2016. Richmond, VIC Australia: Wiley-Blackwell.
Hammerlindl, H., Rad, E. B., Menon, D. R., Hafner, C., Herlyn, M. and Schaider, H. (2016). Notch4 mediated MET-like transition involves crosstalk with non-canonical WNT signalling in melanoma. Asia‐Pacific Combined Dermatology Research Conference 2016, Noosa, QLD Australia, 25–28 August 2016. Richmond, VIC Australia: Wiley-Blackwell.
Al Emran, Abdullah, Menon, Dinoop Ravindran, Soyer, Peter, Gabrielli, Brian, Sturm, Rick, Herlyn, Meenhard and Schaider, Helmut (2016). Global histone modifications define early stress induced drug tolerance in cancer. American-Association-for-Cancer-Research (AACR) Special Conference on Chromatin and Epigenetics in Cancer, Atlanta, GA, United States, 24-27 September 2015. Philadelphia, PA United States: American Association for Cancer Research. doi: 10.1158/1538-7445.CHROMEPI15-B34
Stark, M., Gray, E., Ziman, M., Soyer, H. P. and Schaider, H. (2016). Can melanoma treatment be guided by a panel of predictive and prognostic microRNA biomarkers?. 16th World Congress on Cancers of the Skin , Vienna, Austria, 31 August - 3 September 2016. Philadelphia, PA United States: Lippincott Williams & Wilkins.
Schaider, H., Menon, D. R., Emran, A., Gabrielli, B., Haass, N., Somasundaram, R. and Herlyn, M. (2016). Stress induced multi-drug tolerance precedes acquired drug resistance in melanoma. 26th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, Barcelona Spain, 18-21 November 2014. Richmond, VIC Australia: Wiley-Blackwell .
Emran, A. A., Menon, D. R., Marzese, D., Hammerlindl, H., Brafford, P., Stark, M., Huang, S., Hammerlindl, S., Gupta, D., Soyer, P., Sturm, R., Hoon, D., Gabrielli, B., Herlyn, M. and Schaider, H. (2016). Epigenetic remodelling of H3K9Me3 leads to early stress induced drug tolerance in cancer. Asia‐Pacific Combined Dermatology Research Conference 2016, Noosa, QLD Australia, 25–28 August 2016. Richmond, VIC Australia: Wiley-Blackwell.
Ahmed, F., Tonnessen, C., Spoerri, L., Daignault, S., Stark, M., Schaider, H., Hill, M. and Haass, N. (2016). Identification of unique molecular signatures of differentially cycling tumour cell subpopulations in a 3D melanoma model. Asia-Pacific Combined Dermatology Research Conference 2016, Noosa, QLD Australia, 25–28 August 2016. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/ajd.12584
Rad, E. Bonyadi, Hammerlindl, H., Wels, C., Menon, D., Soyer, H. P., Bergler, H. and Schaider, H. (2015). Notch4 drives mesenchymal-epithelial transition in melanoma. 42nd Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung (ADF), Ulm, Germany, 05-07 March 2015. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/exd.12623
Tan, Jean-Marie, Lin, Lynlee L., Lambie, Duncan, Ong, Natalie, Flewell-Smith, Ross, Jagirdar, Kasturee, Schaider, Helmut, Sturm, Richard A., Prow, Tarl W. and Soyer, H. Peter (2015). Feasibility of genotyping melanocytic lesions by microsampling. 73rd Annual Meeting of the American Academy of Dermatology, San Francisco, California, 20–24 March 2015. Philadelphia, PA United States: Mosby.
Troppan, Katharina, Wenzl, Kerstin, Neumeister, Peter, Beham-Schmid, Christine, Przekopowitz, Martina, Greinix, Hildegard T., Schaider, Helmut and Deutsch, Alexander J. A. (2015). The Chemokine Receptor Profile As Distinctive Criterion Between Normal B-Cell Subsets and As Potential Discriminative Marker to Identify the Cell of Origin in Patients with Chronic Lymphocytic Leukemia and Richter Syndrome. 55th Annual Meeting and Exposition of the American-Society-of-Hematology, New Orleans LA, United States, 7-10 December 2013. Washington, DC United States: American Society of Hematology.
Menon, Dinoop Ravindran, Das, Suman, Krepler, Clemens, Vultur, Adina, Zhang, Gao, Haass, Nikolas, Soyer, Peter H., Gabrielli, Brian, Somasundaram, Rajasekharan, Hoefler, Gerald, Herlyn, Meenhard and Schaider, Helmut (2015). An early innate stress response precedes acquired drug resistance in melanoma. 106th Annual Meeting of the American-Association-for-Cancer-Research (AACR), Philadelphia Pa United States, April 18-22, 2015. Philadelphia, PA United States: American Association for Cancer Research. doi: 10.1158/1538-7445.AM2015-2684
Ong, N., Duffy, D., Leikvold, A., Lee, K., Jagirdar, K., Lin, Lynlee L., Yamada, M., Sturm, R. A., Prow, T. W., Schaider, H. and Soyer, H. P. (2015). Molecular profiles of reticular and globular naevus patterns: a pilot study. 48th Annual Scientific Meeting of the Australasian College of Dermatologists, Adelaide SA, Australia, 16 May 2015. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/ajd.12337
Menon, D. R., Das, S., Krepler, C., Vultur, A., Rinner, B., Schauer, S., Kashofer, K., Wagner, K., Zhang, G., Rad, E. Bonyadi, Soyer, H. P., Gabrielli, B., Somasundaram, R., Hoefler, G., Herlyn, M. and Schaider, H. (2014). A stress induced early innate response causes multi-drug tolerance in melanoma. 26th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, Barcelona Spain, Nov 18-21, 2014. OXFORD: ELSEVIER SCI LTD. doi: 10.1016/S0959-8049(14)70219-9
Rakić, Aleksandar, Taimre, Thomas, Bertling, Karl, Lim, Yah Leng, Wilson, Stephen J., Nikolić, Milan, Valavanis, Alexander, Indjin, Dragan, Linfield, Edmund H., Davies, A. Giles, Ferguson, Blake, Walker, Graeme, Schaider, Helmut and Soyer, H. Peter (2014). THz QCL self-mixing interferometry for biomedical applications. SPIE Optical Engineering + Applications Conference 2014, San Diego, United States, 17-21 August 2014. Bellingham, WA, United States: S P I E - International Society for Optical Engineering. doi: 10.1117/12.2061433
McClenahan, P., Lin, L., Tan, J. M., Smith, R. Flewell, Schaider, H., Jagirdar, K., Lambie, D., Prow, T. W., Sturm, R. A. and Soyer, H. P. (2014). BRAF mutations in an involuting and non-involuting naevus upon BRAF +/- MEK treatment. The Australasian College of Dermatologists 47th Annual Scientific Meeting, Melbourne Australia, 18–21 May 2014. Richmond Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/ajd.12174
Rad, E. Bonyadi, Hammerlindl, H., Menon, D. R., Soyer, H. P., Bergler, H. and Schaider, H. (2014). The intracellular domain of Notch4 suppresses Twist1 and Slug through activation of Hey-1 and Hey-2. 41st Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung (ADF), Cologne, Germany, 13-15 March 2014. West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/exd.12314
Wenzl, K., Troppan, K., Pursche, B., Schaider, H., Beham-Schmid, C., Deutsch, A. and Neumeister, P. (2014). Patients with aggressive B-cell lymphomas display distinct chemokine receptor profile and an association of low CCR7 expression and favorable cancer specific survival. Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, Hamburg Germany, 10-14 October 2014. Basel, Switzerland: S Karger AG. doi: 10.1159/000368945
Riedl, Sabrina, Rinner, Beate, Rechberger, Gerald, Schaider, Helmut, Lohner, Karl and Zweytick, Dagmar (2014). Interaction of an antitumor peptide with lipids of the cancer plasma membrane - Formation of membrane domains and influence of cholesterol. 58th Annual Meeting of the Biophysical-Society, San Francisco United States, Feb 15-19, 2014. St. Louis, United States: Cell Press. doi: 10.1016/j.bpj.2013.11.558
Riedl, Sabrina, Rinner, Beate, Schaider, Helmut, Lohner, Karl and Zweytick, Dagmar (2014). Human lactoferricin derivatives as new targeted weapons in cancer therapy. 58th Annual Meeting of the Biophysical-Society, San Francisco United States, Feb 15-19, 2014. St. Louis, United States: Cell Press. doi: 10.1016/j.bpj.2013.11.554
Riedl, Sabrina, Rinner, Beate, Schaider, Helmut, Asslaber, Martin, Lohner, Karl and Zweytick, Dagmar (2014). Antitumor peptides derived of human Lactoferricin as cancer therapy targeting the membrane lipid phosphatidylserine exposed by malignant melanoma and glioblastoma. 19th World Congress on Advances in Oncology and 17th International Symposium on Molecular Medicine, Athens, Greece, October 9-11, 2014. Athens, Greece: Spandidos Publications.
Troppan, K. T., Wenzl, K., Pursche, B., Schaider, H., Beham-Schmid, C., Deutsch, A. and Neumeister, P. (2014). Distinct chemokine receptor profiles in Richter's transformation compared to de-novo diffuse large B-cell lymphoma and germinal center B-cells. Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, Hamburg, Germany, 10-14 October 2014. Basel, Switzerland: S. Karger AG. doi: 10.1159/000368945
Deutsch, A., Pichler, M., Beham-Schmid, C., Schaider, H. and Neumeister, P. (2013). High expression of CXCR4 and CXCR7 is associated with an advanced stage in aggressive lymphoma. Annual Meeting of the German, Austrian and Swiss Societies of Hematology and Oncology, Vienna, Austria, 18-22 October 2013. Basel, Switzerland: S. Karger AG. doi: 10.1159/000356365
Menon, D. R., Das, S., Rinner, B., Bonyadirad, E., Hoefler, G. and Schaider, H. (2013). Cd271+ve drug tolerant stem like melanoma cells play a crucial role in resistance to BRAF inhibitors. 40th Annual Meeting of the Association-of-Dermatological-Research, Dessau Germany, Mar 14-16, 2013. West Sussex United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/exd.12072
Kretschmer, N., Rinner, B., Deutsch, A., Lohberger, B., Schaider, H. and Bauer, R. (2013). In vitro effects of dimethylacrylshikonin on melanoma cells. 8th World Congress of Melanoma, 9th Congress of the European Association of Dermatology (EADO), 7th Interdisciplinary Melanoma/Skin Cancer Meeting, 3rd European Post-Chicago Melanoma Meeting 2013, Hamburg, Germany, 17-20 July 2013. Berlin, Germany: Wiley-Blackwell Verlag GmbH. doi: 10.1111/ddg.12163
Bonyadirad, E., Popper, U., Wels, C., Menon, D. R. and Schaider, H. (2013). Notch4 mediated regulation of Slug and Twist1 in melanoma. 40th Annual Meeting of the Association-of-Dermatological-Research, Dessau Germany, Mar 14-16, 2013. West Sussex United Kingdom: Wiley Blackwell Publishing. doi: 10.1111/exd.12072
Niederkorn, Anna, Arzberger, Edith, Wurm, Elisabeth M. T., Richtig, Erika, Fink-Puches, Regina, Schaider, Helmut, Wolf, Ingrid H. and Hofmann-Wellenhof, Rainer (2012). Confocal: laser scanning microscopy, a useful complement in the diagnosis of regressive lesions?. WILEY-BLACKWELL. doi: 10.1111/j.1610-0387.2012.08011.x
Menon, D. R., Das, S., Rinner, B., Heike, K., Bonyadirad, E., Hoefler, G. and Schaider, H. (2012). Transient CD271+ve Drug Tolerant Stem Like Melanoma Cells Are Inherently Resistant Towards BRAF And MEK Inhibition. 42nd Annual Meeting of the European-Society-for-Dermatological-Research (ESDR), Venice Italy, Sep 07-10, 2012. NATURE PUBLISHING GROUP.
Menon, D., Wels, C., Rinner, B., Brandner, J. M. and Schaider, H. (2012). TGF-beta1 abrogates whereas TNF-alpha enhances resistance to ERK inhibitors in BRAF mutant melanoma cells through Twist1. 39th Annual Meeting of the Arbeitsgemeinschaft-Dermatologische-Forschung (ADF), Marburg Germany, Mar 01-03, 2012. WILEY-BLACKWELL.
Bohner, C., Pandjaitan, M. A., Haass, N. K., Zorn-Kruppa, M., Moll, I., von den Driesch, P., Schaider, H. and Brandner, J. M. (2012). The role(s) of the junction protein ZO-1 in malignant melanoma. 39th Annual Meeting of the Arbeitsgemeinschaft-Dermatologische-Forschung (ADF), Marburg Germany, Mar 01-03, 2012. WILEY-BLACKWELL.
Joshi, Shripad, Wels, Christian, Fukunaga-Kalabis, Mizuho, Herlyn, Meenhard and Schaider, Helmut (2011). The viral chemokine receptor US28 mediates its anti-tumorigenic effect in melanoma via GNA13. 41st Annual Meeting of the European-Society-for-Dermatological-Research, Barcelona Spain, Sep 07-10, 2011. NATURE PUBLISHING GROUP.
Zweytick, D., Riedl, S., Rinner, B., Asslaber, M., Schaider, H., Walzer, S., Novak, A. and Lohner, K. (2011). In search of new targets - the membrane lipid phosphatidylserine - the underestimated Achilles' Heel of cancer cells. 9th International Symposium on Targeted Anticancer Therapies, Paris France, Mar 07-09, 2011. OXFORD UNIV PRESS.
Riedl, S., Rinner, B., Tumer, S., Schaider, H., Lohner, K. and Zweytick, D. (2011). Targeting the cancer cell membrane specifically with human lactoferricin derivatives. 9th International Symposium on Targeted Anticancer Therapies, Paris France, Mar 07-09, 2011. OXFORD UNIV PRESS.
Bohner, C., Haass, N. K., Vidal-y-Sy, S., Moll, I., von den Driesch, P., Schaider, H. and Brandner, J. (2011). Differential expression of ZO-1 in melanoma and nevi and their tumor microenvironment - an indicator of malignancy. 38th Annual Meeting of the Arbeitsgemeinschaft-Dermatologishche-Forschung, Tuebingen Germany, Feb 17-19, 2011. WILEY-BLACKWELL PUBLISHING, INC.
Wels, C., Joshi, S. and Schaider, H. (2011). Slug augments the epithelial-mesenchymal like transition in melanoma through transcriptional activation of ZEB1. 38th Annual Meeting of the Arbeitsgemeinschaft-Dermatologishche-Forschung, Tuebingen Germany, Feb 17-19, 2011. WILEY-BLACKWELL PUBLISHING, INC.
Menon, Dinoop Ravindran, Wels, Christian, Joshi, Shripad and Schaider, Helmut (2011). Hepatocyte growth factor induces resistance to ERK inhibitors in BRAF mutant melanoma cells through Twist1. 41st Annual Meeting of the European-Society-for-Dermatological-Research, Barcelona Spain, Sep 07-10, 2011. NATURE PUBLISHING GROUP.
Bohner, C., Haass, N. K., Moll, I, von den Driesch, P., Schaider, H. and Brandner, J. M. (2011). Different ZO-1 Localization in Melanoma, Nevi and their Tumor-Microenvironment - An Indicator of Malignancy. 46. Tagung der Deutschen Dermatologischen Gesellschaft Vereinigung Deutschsprachiger Dermatologen e. V., Dresden, Germany, 30 March - 2 April 2011. Berlin, Germany: Wiley-Blackwell Verlag GmbH. doi: 10.1111/j.1610-0387.2011.07632.x
Kretschmer, N., Rinner, B., Deutsch, A., Knausz, H., Blunder, M., Kunert, O., Efferth, T., Schaider, H., Boechzelt, H. and Bauer, R. (2010). Effects of dimethylacrylshikonin and epoxyshikonin on melanoma cell lines. 7th Tannin Conference/58th International Congress and Annual Meeting of the Society-for-Medical-Plant-and-Natural-Product-Research, Berlin Germany, Aug 29-Sep 02, 2010. GEORG THIEME VERLAG KG.
Wels, C., Koefinger, P., Joshi, S. and Schaider, H. (2010). Differential regulation of cadherins through Slug and Twist in melanoma. 37th Annual Meeting of the Arbeitsgemeinschaft-Dermatologishche-Forschung, Luebeck Germany, Feb 18-20, 2010. WILEY-BLACKWELL PUBLISHING, INC.
Rinner, Beate, Kretschmer, Nadine, Deutsch, Alexander, Knausz, Heike, Novak, Alexandra, Boechzelt, Helmut, Schaider, Helmut and Bauer, Rudolf (2010). Anti-Cancer Activity of a Petrol Ether Extract of Onosma Paniculatum. 10th Euroconference on Clinical Cell Analysis of the European-Society-for-Clinical-Cell-Analysis (ESCCA)/ Iberian Society-for-Cytometry (SIC), Valencia Spain, Sep 21-25, 2010. WILEY-LISS.
Kretschmer, N., Rinner, B., Knausz, H., Efferth, T., Boechzelt, H., Schaider, H. and Bauer, R. (2009). A petrol ether extract of Onosma paniculatum Bur. & Franch. shows strong anti-proliferative activity and induces apoptosis in human cancer cell lines. 55th International Congress and Annual Meeting of the Society-for-Medicinal-Plant-Research-and-Natural-Product-Research, Geneva Switzerland, Aug 16-20, 2009. GEORG THIEME VERLAG KG.
Damm, S., Wels, C., Koefinger, P., Stefan, M., Mehes, G., Richtig, E., Kerl, H., Otte, M. and Schaider, H. (2009). Hepatocyte growth factor promotes motility in human melanocytes through CD44v6 via NF-kappa B. 36th Annual Meeting of the Arbeitsgemeinschaft-Dermatologishche-Forschung, Heidelberg Germany, Mar 05-07, 2009. WILEY-BLACKWELL PUBLISHING, INC.
Koefinger, P., Wels, C., Damm, S., Kerl, H., Herlyn, M. and Schaider, H. (2008). Stage-specific effects of Hepatocyte Growth Factor on epithelial-mesenchymal transcriptional regulators in melanocylic cells. International Investigative Dermatology Meeting, Kyoto Japan, May 14-17, 2008. NATURE PUBLISHING GROUP.
Wels, C., Koefinger, P., Damm, S., Papic, L., Kerl, H., Herlyn, M. and Schaider, H. (2008). Effect of hepatocyte growth factor on the expression of Wnts and Wnt regulators in melanoma. 35th Annual Meeting of the Arbeitsgemeinschaft-Dermatolog-Forschung, Eriangen Germany, Feb 28-Mar 01, 2008. BLACKWELL PUBLISHING.
Koefinger, P., Wels, C., Kerl, H., Herlyn, M. and Schaider, H. (2008). Stage-specific effects of Hepatocyte growth factor on snail, slug, twist and Src in melanoma. 35th Annual Meeting of the Arbeitsgemeinschaft-Dermatolog-Forschung, Eriangen Germany, Feb 28-Mar 01, 2008. BLACKWELL PUBLISHING.
Damm, S., Koefinger, P., Stefan, M., Wels, C., Mebes, G., Kerl, H., Otte, M. and Schaider, H. (2008). Expression of CD44v6 in Melanocytic Lesions and Influence of the hepatocyte growth factor on the expression of CD44v6 in Melanocytes and Melanoma cell lines. 35th Annual Meeting of the Arbeitsgemeinschaft-Dermatolog-Forschung, Eriangen Germany, Feb 28-Mar 01, 2008. BLACKWELL PUBLISHING.
Deutsch, Alexander J. A., Aigelsreiter, Ariane, Steinbauer, Elisabeth, Linkesch, Werner, Beham-Schmid, Christine, Schaider, Helmut and Neumeister, Peter (2007). Chemokine receptor expression profile in the model of parotid MALT lymphomagenesis: De novo expression of CXCR6.. 49th Annual Meeting of the American-Society-of-Hematology, Atlanta Ga, Dec 08-11, 2007. AMER SOC HEMATOLOGY.
Schaider, H., Seidl, H., Quan, P., Frank, S., Liu, Z., Fukunaga, M., McDaid, R., Kerl, H., Waldhoer, M. and Herlyn, M. (2007). A signaling mute hCMV chemokine receptor prevents melanoma growth. 34th Annual Meeting of the Arbeitsgemeinschaft-Dermatologische-Forschung, Freiburg Germany, Mar 08, 2004-Mar 10, 2007. BLACKWELL PUBLISHING.
Papic, L., Koefinger, P., Seidl, H., Prem, A., Quan, P., Kerl, H., Herlyn, M. and Schaider, H. (2007). Relevance of PDGF receptors to the pathogenesis of desmoplastic malignant melanoma. 34th Annual Meeting of the Arbeitsgemeinschaft-Dermatologische-Forschung, Freiburg Germany, Mar 08, 2004-Mar 10, 2007. BLACKWELL PUBLISHING.
Koefinger, P., Papic, L., Quan, P., Kerl, H., Herlyn, M. and Schaider, H. (2007). Mechanisms of hepatocyte growth factor induced regulation of cell adhesion in melanocytic cells. 34th Annual Meeting of the Arbeitsgemeinschaft-Dermatologische-Forschung, Freiburg Germany, Mar 08, 2004-Mar 10, 2007. BLACKWELL PUBLISHING.
Quan, P., Richtig, E., Seidl, H., Stefan, M., Tilz, H., Asslaber, M., Schmidbauer, U., Zatloukal, K., Kerl, H. and Schaider, H. (2007). Expression profiles of chemokine receptors in melanoma metastases. 34th Annual Meeting of the Arbeitsgemeinschaft-Dermatologische-Forschung, Freiburg Germany, Mar 08, 2004-Mar 10, 2007. BLACKWELL PUBLISHING.
Aigelsreiter, A., Deutsch, A. J. A., Stelzl, E., Beham-Schmid, C., Beham, A., Linkesch, W., Schaider, H., Kessler, H. H. and Neumeister, P. (2007). Different chemokine receptor expression profile in extragastric and gastric MALT-lymphomas. 96th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology, San Diego Ca, Mar 24-30, 2007. NATURE PUBLISHING GROUP.
Barounig, A., Roschger, A., Quan, P., Michelitsch, U., Baeck, B., Kerl, H., Wolf, P. and Schaider, H. (2007). Chemokine and chemokine receptor profiles in keratinocytes, fibroblasts and melanocytic cells after UVB irradiation. 34th Annual Meeting of the Arbeitsgemeinschaft-Dermatologische-Forschung, Freiburg Germany, Mar 08, 2004-Mar 10, 2007. BLACKWELL PUBLISHING.
Seidl, H., Schaider, H., Quan, P., Frank, S., Liu, Z., Fukunaga, M., McDaid, R., Kerl, H., Herlyn, M. and Waldhoer, M. (2006). The signaling mute hCMV chemokine receptor US28R129A prevents melanoma growth. 12th Symposium of the Austrian-Pharmacological-Society, Vienna Austria, Nov 23-25, 2006. KARGER.
Malischnika, C, Rohde, E, Thaler, D, Vogel, B, Linkesch, W, Lanzer, G, Schaider, H and Strunk, D (2005). Low plating density boosts mesenchymal stem cell proliferation. 31st Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation/21st Meeting of the EBMT-Nurses-Group/4th Meeting of the EBMT-Data-Management-Group, Prague Czech Republic, Mar 20-23, 2005. London, United Kingdom: Nature Publishing Group.
Schaider, H, Heider, KH, Soyer, HP, Cerroni, L, Smolle, J and Kerl, H (1996). CD44 standard and splice variants (v5 and v6) depression in melanocytic skin lesions.. CAMBRIDGE: BLACKWELL SCIENCE INC.
Schaider, H, Weichselbraun, I, Richtig, E, Smolle, J and Kerl, H (1995). No Difference in Levels of Soluble Human Icam-1, Pecam-1, Cd44 Standard, and Splice Variants V5, V6, and V10 in Patients with and Without Primary Tumors of Malignant-Melanoma (Pmm). BLACKWELL SCIENCE PUBL INC CAMBRIDGE.
Schaider, H, Peter, W, Fusenig, NE and Berger, MR (1994). Hexadecylphosphocholine Induces a Differential Pattern of Ki-Ras and Ha-Ras Expression in 2 Human Carcinoma Cell-Lines. BLACKWELL SCIENCE INC.